COMMUNIQUÉS West-GlobeNewswire

Press Release: Sanofi in discussions to sell a controlling stake in Opella

11/10/2024 - 08:30

Sanofi in discussions to sell a controlling stake in Opella Paris, October 11, 2024 . Sanofi today announces that the company has entered into negotiations with CD&R for the potential sale of a 50% controlling stake [...]

Communiqué de presse : Sanofi en discussions pour céder une participation majoritaire dans Opella

11/10/2024 - 08:50

Sanofi en discussions pour céder une participation majoritaire dans Opella Paris, 11 octobre 2024 . Sanofi a annoncé aujourd'hui avoir entamé des négociations avec CD&R pour la cession potentielle d’une [...]

Turnstone Biologics Announces Strategic Restructuring to Prioritize Portfolio and Extend Financial Runway

11/10/2024 - 12:00

Realigning resources to focus on clinical advancement of Selected TIL therapy Reducing employee headcount by approximately 60% Streamlining operations with cash runway expected to extend into 2Q 2026 SAN DIEGO, Oct. 11 [...]

Curia s’engage envers la norme de neutralité carbone « net zéro » de la SBTi

11/10/2024 - 12:01

Albany, New York, 11 oct. 2024 (GLOBE NEWSWIRE) -- Curia, une organisation de recherche, de développement et de fabrication sous contrat de première importance fait part ce jour de son engagement à réduire ses émissions [...]

Sagimet Biosciences Announces Publication of Results from Phase 2b FASCINATE-2 Clinical Trial of Denifanstat in Biopsy-Confirmed F2/F3 MASH in The Lancet Gastroenterology & Hepatology

11/10/2024 - 13:00

- Treatment with denifanstat achieved statistically significant and clinically meaningful improvements in disease activity, MASH resolution and fibrosis - - Results support advancement of denifanstat into Phase 3 [...]

NMD Pharma to Present Data on its Skeletal Muscle Targeted Therapy for Rare Neuromuscular Diseases at the 2024 AANEM Annual Meeting

11/10/2024 - 13:00

NMD Pharma to Present Data on its Skeletal Muscle Targeted Therapy for Rare Neuromuscular Diseases at the 2024 AANEM Annual Meeting Aarhus, Denmark, 11 October 2024 – NMD Pharma A/S, a clinical-stage biotech company [...]

Better Choice Company to Expand into Veterinary Medicine in 2025 Following the Acquisition of SRx Health

11/10/2024 - 13:30

TAMPA, Fla., Oct. 11, 2024 (GLOBE NEWSWIRE) -- Better Choice Company (NYSE: BTTR) (“Better Choice” or “the Company”), a pet health and wellness company, today announced expansion plans into veterinary medicine in 2025 [...]

Tourmaline Bio to Showcase Two Poster Presentations at the 2024 Cardiometabolic Health Congress

11/10/2024 - 13:30

NEW YORK, Oct. 11, 2024 (GLOBE NEWSWIRE) -- Tourmaline Bio, Inc. (Tourmaline) (NASDAQ: TRML), a late-stage clinical biotechnology company developing transformative medicines to dramatically improve the lives of patients [...]

Alterity Therapeutics Announces Presentation of New Data Describing Neuroprotection of ATH434 at Neuroscience Meeting

11/10/2024 - 13:35

MELBOURNE, Australia and SAN FRANCISCO, Oct. 11, 2024 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying [...]

Assertio to Participate in the Maxim Group Healthcare Virtual Summit on October 15, 2024

11/10/2024 - 14:00

LAKE FOREST, Ill., Oct. 11, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated [...]

InnovAge Provides Update on Clinical & Operational Transformations at National PACE Association Annual Conference

11/10/2024 - 14:00

Investments in People, Processes and Tools Deliver Enhanced Experience for InnovAge Participants at Company’s 20 Centers DENVER, Oct. 11, 2024 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge”) (Nasdaq: INNV), a [...]

Auron Announces Poster Presentation at 2024 PCF Annual Scientific Retreat

11/10/2024 - 14:00

NEWTON, Mass., Oct. 11, 2024 (GLOBE NEWSWIRE) -- Auron Therapeutics , a biotechnology company focused on developing next-generation targeted therapies by identifying and inhibiting the oncogenic cell states of cancer, [...]

Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

11/10/2024 - 14:00

SOUTH SAN FRANCISCO, Calif., Oct. 11, 2024 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”, “Company”), a clinical stage biopharmaceutical company focused on improving patient outcomes through best [...]

Disc Medicine Announces Presentation of New Data from Phase 1b Trial of DISC-0974 in Patients with Chronic Kidney Disease (CKD) and Anemia at 2024 American Society of Nephrology (ASN) Kidney Week

11/10/2024 - 14:00

WATERTOWN, Mass., Oct. 11, 2024 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for [...]

Alignment Healthcare Continues to Deliver High-Quality Medicare Advantage Plans, 4 Stars or Greater for 98% of Members in 2025

11/10/2024 - 14:00

Medicare Advantage company retains 5- out of 5-star rating in North Carolina and Nevada, California PPO earns 4.5 stars ORANGE, Calif., Oct. 11, 2024 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC) [...]

Nelipak Healthcare Packaging Awarded Silver Medal Sustainability Rating from EcoVadis for Second Consecutive Year

11/10/2024 - 14:00

Nelipak Ranked Among the Top 15% of Surveyed Companies CRANSTON, R.I., Oct. 11, 2024 (GLOBE NEWSWIRE) -- Nelipak Corporation (“Nelipak”), a leading global manufacturer of packaging solutions for medical device, [...]

MaxCyte to Report Third Quarter 2024 Financial Results on November 6, 2024

11/10/2024 - 14:05

ROCKVILLE, Md., Oct. 11, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and [...]

23andMe Announces 1-for-20 Reverse Stock Split

11/10/2024 - 14:15

SUNNYVALE, Calif., Oct. 11, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (the “Company” or “23andMe”), announced today that the 1-for-20 reverse stock split of the Company’s Class A and Class B common stock [...]

INmune Bio Inc. to Participate in the Maxim Healthcare Virtual Summit

11/10/2024 - 14:30

Boca Raton, Florida, Oct. 11, 2024 (GLOBE NEWSWIRE) -- INmune Bio Inc . (NASDAQ: INMB) (the “Company”), a clinical-stage inflammation and immunology company targeting microglial activation and neuroinflammation as a [...]